The interaction between bromelain and EGFR observed in our study could indicate that bromelain might interfere with EGFR-mediated activation of the PI3K/Akt pathway, thereby potentially reducing NPC progression. The gene discussed is PIK3CA; the disease is nasopharyngeal carcinoma.